Performance characteristics of the IMMULITE 2000 erythropoietin assay

William E. Owen; William L. Roberts

doi:10.1016/j.cccn.2003.11.005

Performance characteristics of the IMMULITE 2000 erythropoietin assay

William E. Owen, William L. Roberts

Research output: Contribution to journal › Article › peer-review

26 Scopus citations

Abstract

Background: Erythropoietin (EPO) is a glycoprotein hormone produced by specialized cells in the kidney that acts as the primary regulator of erythropoiesis. Serum EPO measurements are useful for diagnostic evaluations of anemia and polycythemia. Methods: The IMMULITE 2000 is an automated random access immunoassay analyzer for the central laboratory. The limit of detection (LOD), linearity, imprecision, comparison to another commercially available assay, and reference interval of a new EPO assay for this analyzer were assessed. Results: The LOD was 0.2 U/l. The assay was linear within an allowable systematic error of 10% over the range tested (2-178 U/l). The total imprecision of the new assay was

Original language	English (US)
Pages (from-to)	213-217
Number of pages	5
Journal	Clinica Chimica Acta
Volume	340
Issue number	1-2
DOIs	https://doi.org/10.1016/j.cccn.2003.11.005
State	Published - Jan 1 2004
Externally published	Yes

Bibliographical note

Generated from Scopus record by KAUST IRTS on 2023-09-20

ASJC Scopus subject areas

Biochemistry
Clinical Biochemistry
Biochemistry, medical

Access to Document

10.1016/j.cccn.2003.11.005

Cite this

@article{bf3e71ea812d4323b6c1a3769a25c469,

title = "Performance characteristics of the IMMULITE 2000 erythropoietin assay",

abstract = "Background: Erythropoietin (EPO) is a glycoprotein hormone produced by specialized cells in the kidney that acts as the primary regulator of erythropoiesis. Serum EPO measurements are useful for diagnostic evaluations of anemia and polycythemia. Methods: The IMMULITE 2000 is an automated random access immunoassay analyzer for the central laboratory. The limit of detection (LOD), linearity, imprecision, comparison to another commercially available assay, and reference interval of a new EPO assay for this analyzer were assessed. Results: The LOD was 0.2 U/l. The assay was linear within an allowable systematic error of 10% over the range tested (2-178 U/l). The total imprecision of the new assay was",

author = "Owen, {William E.} and Roberts, {William L.}",

note = "Generated from Scopus record by KAUST IRTS on 2023-09-20",

year = "2004",

month = jan,

day = "1",

doi = "10.1016/j.cccn.2003.11.005",

language = "English (US)",

volume = "340",

pages = "213--217",

journal = "Clinica Chimica Acta",

issn = "0009-8981",

publisher = "Elsevier B.V.",

number = "1-2",

}

TY - JOUR

T1 - Performance characteristics of the IMMULITE 2000 erythropoietin assay

AU - Owen, William E.

AU - Roberts, William L.

N1 - Generated from Scopus record by KAUST IRTS on 2023-09-20

PY - 2004/1/1

Y1 - 2004/1/1

N2 - Background: Erythropoietin (EPO) is a glycoprotein hormone produced by specialized cells in the kidney that acts as the primary regulator of erythropoiesis. Serum EPO measurements are useful for diagnostic evaluations of anemia and polycythemia. Methods: The IMMULITE 2000 is an automated random access immunoassay analyzer for the central laboratory. The limit of detection (LOD), linearity, imprecision, comparison to another commercially available assay, and reference interval of a new EPO assay for this analyzer were assessed. Results: The LOD was 0.2 U/l. The assay was linear within an allowable systematic error of 10% over the range tested (2-178 U/l). The total imprecision of the new assay was

AB - Background: Erythropoietin (EPO) is a glycoprotein hormone produced by specialized cells in the kidney that acts as the primary regulator of erythropoiesis. Serum EPO measurements are useful for diagnostic evaluations of anemia and polycythemia. Methods: The IMMULITE 2000 is an automated random access immunoassay analyzer for the central laboratory. The limit of detection (LOD), linearity, imprecision, comparison to another commercially available assay, and reference interval of a new EPO assay for this analyzer were assessed. Results: The LOD was 0.2 U/l. The assay was linear within an allowable systematic error of 10% over the range tested (2-178 U/l). The total imprecision of the new assay was

UR - https://linkinghub.elsevier.com/retrieve/pii/S0009898103005242

UR - http://www.scopus.com/inward/record.url?scp=0842330774&partnerID=8YFLogxK

U2 - 10.1016/j.cccn.2003.11.005

DO - 10.1016/j.cccn.2003.11.005

M3 - Article

SN - 0009-8981

VL - 340

SP - 213

EP - 217

JO - Clinica Chimica Acta

JF - Clinica Chimica Acta

IS - 1-2

ER -

Performance characteristics of the IMMULITE 2000 erythropoietin assay

Abstract

Bibliographical note

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this